Effect of AT1 angiotensin receptor antagonist on lipid peroxidation and antioxidative defense in diabetic kidney

Pathophysiology

Volumn 6, Issue 4, 2000, Pages 245-249

  Kedziora Kornatowska, K ^a   Luciak, M ^a   Blaszczyk, J ^a   Pawlak, W ^a   Kedziora, J ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Angiotensin receptors; Angiotensin converting enzyme; Catalase; Diabetes; Lipid peroxidation; Oxidative stress; Superoxide dismutase

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CATALASE; GLUCOSE; HEMOGLOBIN A1C; LOSARTAN POTASSIUM; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; KIDNEY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA; RAT; STREPTOZOCIN DIABETES;

EID: 0033984011     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4680(99)00028-0     Document Type: Article

References (35)

1. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care. 15:1992;1835-1843.
2. Nath N., Chari S.N., Rathi A.B. Superoxide dismutase in diabetic polymorphonuclear leukocytes. Diabetes. 33:1984;586-589.
3. Baynes J.W. Role of oxidative stress in the development of complications in diabetes. Diabetes. 40:1991;405-412.
4. Larkins G.R., Dunlop M.E. The link between hyperglycaemia and diabetic nephropathy. Diabetologia. 35:1992;499-504.
5. Wolf G., Thaiss F. Hyperglycaemia - pathophysiological aspects at the cellular level. Nephrol. Dial. Transplant. 10:1995;1109-1112.
6. Ayo S.A., Radnik G., Garoni J., Troyer D.A., Kreisberg J.I. High glucose increases diacylglycerol and activates protein kinase C in mesangial cell cultures. Am. J. Physiol. 26:1991;F571-F577.
7. Bakris G.L. Angiotensin-convertng enzyme inhibitors in the progression of diabetic nephropathy. Ann. Intern. Med. 118:1993;643-644.
8. Bain S.C., le Guen C.A., Lunec J. Comparison of the free radical scavenging activity of captopril versus enalapril: a 3 month in vivo study in hypertensive diabetic patients. J. Hum. Hypertens. 5:1991;511-515.
9. Remuzzi A., Perico N., Amuchastegui C.S., Malanchini B., Mazerska M., Battaglia C., Bertani T., Remuzzi G. Short and long-term effect of angiotensin receptor blockade in rats with experimental diabetes. Am. J. Soc. Nephrol. 4:1993;40-49.
10. Cohen M.P., Klein C.V. Glomerulopathy in rats with streptozotocin diabetes. J. Exp. Med. 149:1979;623-631.
11. R.F. Del Maestro, W. McDonald, Oxidative enzymes in tissue homogenates, in: R.A. Greenwald (Ed.), CRC Handbook of Methods for Oxygen Radical Research, CRC Press, Boca Raton, 1986, pp. 291-296.
12. Misra H.P., Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 247:1972;3170-3175.
13. Beers R., Sizer J.W. Spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 195:1952;133-140.
14. Placer Z., Cushiman Z., Janson B. Estimation of products of lipid peroxidation, malondialdehyde in biochemical systems. Anal. Biochem. 16:1966;359-364.
15. Shah S.V. Role of reactive oxygen metabolises in experimental glomerular disease. Kidney Int. 35:1989;1093-1106.
16. Ohkawa H., Ohishi N., Yagi R. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:1979;351-358.
17. Lammi-Keefe C.J., Swan P.B., Hegarty P.V.J. Evidence for increased peroxidative activity in muscles from streptozotocin-diabetes rats. Proc. Soc. Exp. Biol. Med. 176:1984;27-31.
18. Asayama K., Hayashibe H., Dobashi K., Niitsu T., Miyao A., Kato K. Antioxidant enzyme status and lipid peroxidation in various tissues of diabetic and starved rats. Diabetes Res. 12:1989;85-91.
19. Loven D., Schedl A., Wilson H., Daabees T.T., Stegink L.D., Diekus M., Oberley L. Effect of insulin and oral glutatione on glutathione levels and superoxide dismutase activities in organs of rats with streptozotocin-induced diabetes. Diabetes. 35:1986;503-507.
20. D.P. Loven, H.P. Shede, L. Oberley, H.D. Wilson, I. Brucj, C. Niehaus, Superoxide dismutase activity in the intestine of the streptozotocin-diabetic rat, Endocrinology 111, (1982) 737-742.
21. Wohaieb S.A., Godin D.V. Alterations in free radical tissue defense mechanisms in Streptozotocin-induced diabetes in rat. Diabetes. 36:1987;1014-1018.
22. Golik A., Weissgarten J., Evans S., Cohen N., Zaidenstein R., Modai D., Cotariu D. Changes in red blood cell glutathione and glutathione dependent enzymes on long-term treatment with captopril and enalapril. Clin. Chim. Acta. 240:1995;89-94.
23. Wolf G., Ziyadeh F.N. The role of angiotensin II in diabetic nephropathy. Emphasis on nonhemodynamic mechanism. Am. J. Kidney Dis. 29:1997;153-163.
24. Ha H., Kim K.H. Role of oxidative stress in the development of diabetic nephropathy. Kidney Int. 48:1995;18-21.
25. Kreisberg J.I., Kreisberg S.H. High glucose activates protein kinase C and stimulates fibronectin expression by enhancing a cAMP response element. Kidney Int. 48:1995;S3-S11.
26. Kim S., Ohta K., Hamaguchi A., Omura T., Yukimura T., Miura K., Inada Y., Wada T., Ischimura Y., Chatani F., Iwso H. Role of angiotensin II in renal injury of deoxycorticosteron acetate-salt hypertensive rats. Hypertension. 24:1994;195-204.
27. Ichikawa J. Will angiotensin II receptor antagonists be renoprotective in humans? Kidney Int. 50:1996;684-692.
28. Johnston C.I. Angiotensin receptor antagonists: foxus on losartan. Lancet. 346:1995;1403-1407.
29. Liu F.Y., Cogan M.G. Role of protein kinase C in proximal bicarbonate absorption and angiotensin signaling. Am. J. Physiol. 258:1990;F927-F933.
30. Sash S.V. Light emission by isolated rat glomeruli in response to phorbol myristate acetate. J. Lab. Clin. Med. 98:1981;46-56.
31. Ha H., Yoon S.J., Kim K.H. High glucose can induce lipid peroxidation in the isolated rat glomeruli. Kidney Int. 46:1994;1620-1626.
32. Craven P.A., Davidson C.M., De Rubertis F.R. Increase in diacylplycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes. 39:1990;667-674.
33. Williams B., Schrier R.W. Glucose induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells. J. Clin. Invest. 92:1993;2889-2896.
34. Tesfamariam B., Cohen R.A. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am. J. Physiol. 263:1992;H321-H326.
35. Salahudeen A.K., Kanji V., Reckelhoff J.F., Schmidt A.M. Pathogenesis of diabetic nephropathy: a radical approach. Nephrol. Dial. Transplant. 12:1997;664-668.